Data Foundry

Medical device recalls 2017

Dimension Vista Estradiol — Class II medical device recall Z-2608-2017

Terminated recall by Siemens Healthcare Diagnostics, Inc., reported 2017-06-28, distributed nationwide. The concentrations for Biotin listed in the Non-Interfering Substances section of the current Dimension and Di

Recall numberZ-2608-2017
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSiemens Healthcare Diagnostics, Inc., Newark, DE, United States
Recall initiated2017-03-21
Classified2017-06-16
Reported by FDA2017-06-28
Terminated2018-08-03
DistributedNationwide (US)
Countries outside the USAE, AR, AT, AU, BD, BE, BR, CA, CH, CN, CZ, DE, DK, DZ, EG, ES, FI, FR, GB, GR, HR, ID, IE, IN, IT, JP, KR, KW, LB, LV, NL, NO, NZ, PH, PL, PT, QA, SA, SI, SK, TR, TW, ZA
Quantity1,697 units
Lot numbers16148AA, 16190BA, 16201BA, 16228BC, 16256BA, 16277BB, 16298AB, 16343BE, 17005BC

Product

Dimension Vista Estradiol (E2) Flex reagent cartridge

Reason for recall

The concentrations for Biotin listed in the Non-Interfering Substances section of the current Dimension and Dimension Vistat Instructions for Use (IFU) for Dimension TNI, Dimension Vista DIGXN, E2, FERR, PRL, and TSH have incorrect units, and incorrectly state the level at which biotin does not interfere.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2608-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.